JonathanCorrenMD
Allergy & Immunology • Los Angeles, CAAsthma & Allergic Conditions, Clinical & Laboratory Immunology
Allergy Medical Clinic
Dr. Corren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10780 Santa Monica Blvd
Suite 280
Los Angeles, CA 90025Phone+1 310-312-5050Fax+1 310-575-9292
Education & Training
University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1988 - 1990
University of California Davis HealthResidency, Internal Medicine, 1985 - 1987
University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 1983 - 1984
University of California San Diego School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1984 - 2026
CO State Medical License 1990 - 1993- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Control of Asthma Patients Symptomatic on Inhaled Corticosteroids Start of enrollment: 2006 May 01
- Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy Start of enrollment: 2015 Mar 03
Publications & Presentations
PubMed
- 3 citationsTezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types.Reynold Panettieri Jr, Njira Lugogo, Jonathan Corren, Christopher S Ambrose
Journal of Asthma and Allergy. 2024-01-01 - 459 citationsTezepelumab in Adults with Uncontrolled AsthmaJonathan Corren, Jane R. Parnes, Liangwei Wang, May Mo, Stephanie L. Roseti
The New England Journal of Medicine. 2017-09-06 - 359 citationsTezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.Andrew Menzies-gow, Jonathan Corren, Arnaud Bourdin, Geoffrey Chupp, Elliot Israel
The New England Journal of Medicine. 2021-05-12
Journal Articles
- Editorial How Important Is Adherence to Inhaled Medications Before Starting a Biologic Therapy for Asthma?Jonathan Corren, MD, ScienceDirect
Press Mentions
Add Tezepelumab to SCIT to Improve Cat Allergy Symptoms?November 21st, 2022- Add Tezepelumab to SCIT to Improve Cat Allergy Symptoms?November 18th, 2022
- Fight Cat Allergies with Newest Asthma Drug?October 13th, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
